Matthew Cohen

Matthew Cohen

Private Equity Investor at
OUP Management Co. LLC
Consumer Services
Commercial Services
Finance

Profile

Matt joined OUP in 2013 and focuses on investments in therapeutics, diagnostics, medical devices, and research tools.
He has been involved with OUP’s investment in several portfolio companies including Biohaven Pharma (NYSE: BHVN), Synthorx (acquired by Sanofi), Kura Oncology (NASDAQ: KURA), Spero Therapeutics (NASDAQ: SPRO), Cell Design Labs (acquired by Gilead), Arrakis Therapeutics, PMV Pharma (NASDAQ: PMVP), Aerovate Therapeutics (NASDAQ: AVTE), Sana Biotechnology (NASDAQ: SANA), and others.
Currently, Matt sits on the board of Coho Therapeutics and IMMvention Therapeutix and holds board observer seats at Arrakis Therapeutics and Faraday Pharma.
Prior to joining OUP, Matt was a strategy consultant with L.E.K.
Consulting serving clients in biopharma, diagnostics, research tools, healthcare, and private equity.
Engagements included strategy development, market assessment, commercialization support, portfolio development, acquisition target identification, and diligence / transaction support.
As a Ph.D.
student at the University of Pennsylvania Matt conducted research on the antibody response to a novel protein-based poxvirus vaccine and advised several startups while working with the Penn Biotech Group.
Matt holds a Ph.D.
in Cell and Molecular Biology from The University of Pennsylvania, and a B.S.
in Microbiology from The Pennsylvania State University.
Matt resides in Gladwyne, PA with his wife Jenna and their two children.

Matthew Cohen active positions

CompaniesPositionStart
Private Equity Investor 2018-12-31

Former positions of Matthew Cohen

CompaniesPositionEnd
Consultant / Advisor 2012-12-30
SPERO THERAPEUTICS, INC. Director/Board Member -
See the detail of Matthew Cohen's experience

Training of Matthew Cohen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

39

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Consumer Services

Commercial Services

Consumer Services

Finance

Health Technology